MB, Levis & Associates’s iShares iBonds Dec 2029 Term Corporate ETF IBDU Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
– Sell
-533,909
Closed -$12.1M – 293
2024
Q2
$12.1M Buy
533,909
+12,868
+2% +$290K 6.36% 7
2024
Q1
$11.9M Buy
521,041
+12,656
+2% +$289K 6.38% 7
2023
Q4
$11.7M Buy
508,385
+22,239
+5% +$493K 6.71% 7
2023
Q3
$10.6M Buy
486,146
+7,389
+2% +$164K 6.9% 5
2023
Q2
$10.7M Buy
478,757
+75,270
+19% +$1.71M 6.89% 7
2023
Q1
$9.23M Buy
403,487
+38,048
+10% +$860K 6.42% 7
2022
Q4
$8.1M Buy
+365,439
New +$8.05M 6.34% 6

Other funds holding IBDU

MB, Levis & Associates's IBDU Position: Q3 2024 in Review

MB, Levis & Associates sold out of iShares iBonds Dec 2029 Term Corporate ETF (IBDU) in Q3 2024, closing a stake of 533,909 shares — an estimated $12.1M sold.

MB, Levis & Associates first reported a position in IBDU in Q4 2022 and held it in 7 quarters. The position peaked at $12.1M in Q2 2024. 227 funds tracked by Wall St. Rank hold IBDU as of Q3 2024.

  • MB, Levis & Associates reported no remaining iShares iBonds Dec 2029 Term Corporate ETF position as of Q3 2024 after selling out during the quarter.
  • MB, Levis & Associates sold 533,909 iShares iBonds Dec 2029 Term Corporate ETF shares in Q3 2024, an estimated $12.1M.
  • MB, Levis & Associates first reported a position in iShares iBonds Dec 2029 Term Corporate ETF in Q4 2022 and held it in 7 quarters.
  • MB, Levis & Associates's iShares iBonds Dec 2029 Term Corporate ETF position peaked at $12.1M in Q2 2024.
  • 227 funds tracked by Wall St. Rank held iShares iBonds Dec 2029 Term Corporate ETF as of Q3 2024.

Based on MB, Levis & Associates's 13F filing for Q3 2024, filed 7 May 2025.